SPR for Small Molecule-Protein Binding: Solubility, DMSO Compatibility, and Practical Sample Preparation

The DMSO Problem: Why Solvent Correction Is Mandatory for Small Molecule SPR

Small molecules and fragments (MW < 1,000 Da) are typically stored in 100% DMSO and diluted into aqueous running buffer for SPR analysis. DMSO has a significantly higher refractive index than water—on a typical Biacore CM5 setup, 1% DMSO produces approximately 1,200 RU of raw bulk response. By linear scaling, a 0.1% DMSO mismatch between sample and running buffer gives roughly 10–15 RU of raw bulk artifact, which after flow cell subtraction (Fc2 − Fc1) reduces to a few RU of residual. That residual is comparable to or larger than a typical fragment binding signal (2–10 RU). Without correction, genuine hits are indistinguishable from DMSO-induced drift — a problem well-documented in large-scale fragment screening campaigns where DMSO solvent correction protocols are integrated into standard Biacore workflows (Giannetti, 2011).

The excluded volume effect

The carboxymethyl-dextran matrix on the sensor chip swells and contracts depending on solvent composition. Because the active (ligand-loaded) surface has protein occupying dextran-accessible volume, it contains less mobile DMSO under the evanescent field than the reference surface. This buffer-displacement effect means the two surfaces respond differently to the same bulk DMSO concentration, creating a systematic artifact that cannot be removed by simple reference subtraction alone. Solvent correction maps this surface-pair difference by constructing a calibration curve.

When solvent correction is needed

For an introduction to SPR principles, refer to our SPR technology guide.

Solvent Correction Protocol: Step by Step

Step 1: Prepare running buffer with exact DMSO percentage

Determine the target DMSO concentration (typically 1–5%, most commonly 2–5%). Prepare a single batch of running buffer containing the exact target DMSO percentage. Use the same DMSO bottle for the duration of a screen—DMSO refractive index varies batch-to-batch.

Step 2: Prepare the DMSO calibration series

Prepare 8 calibration solutions bracketing the target DMSO concentration. The spread should cover approximately −500 to +1,000–1,500 RU in bulk response around the running buffer. Skew points toward the high-RI side to account for evaporation drift.

Step 3: Inject calibration standards

Inject the DMSO calibration series over both the reference and active flow cells at the start. Use the same injection parameters as for analyte samples. Re-inject periodically during long runs (every 50–100 cycles) and at the end.

Step 4: Generate the solvent correction curve

The software plots (active − reference) bulk response vs. reference bulk response and fits a second-order polynomial. This calibration curve maps the surface-pair difference in DMSO response and accounts for the excluded volume contribution.

Step 5: Apply correction to sample data

For each sample injection, the software interpolates the DMSO-dependent bulk contribution from the calibration curve and subtracts it. After correction, the calibration points should form a flat line near zero RU.

Step 6: Verify calibration quality

• Fit R² > 0.99
• All sample bulk responses fall within the calibrated range
• Re-inject a buffer-only sample containing target DMSO—post-correction response should be near zero

For detailed sensorgram interpretation, see our SPR sensorgram analysis guide.

DMSO solvent correction workflow for small molecule SPR: calibration series injection, bulk response measurement, and second-order polynomial fitting to correct DMSO-induced refractive index artifacts.

Assessing Small Molecule Solubility Before the SPR Run

Compound aggregation is the most frequently underestimated source of SPR artifacts. Aggregates produce large, non-specific responses easily mistaken for binding.

Pre-solubility screening checklist

If compound shows poor solubility

• Reduce the top concentration
• Adjust DMSO content within the 1–5% range
• Test alternative co-solvents: ethanol (≤2%), acetonitrile (≤1%)—requires dedicated solvent correction
• Add compatible detergent (0.005–0.05% P20)

For complementary binding validation methods, see our ITC guide for protein-ligand interactions.

Impact of compound solubility screening on SPR data quality: aggregated compound (left) produces spiky, unreliable sensorgrams; properly screened compound (right) yields clean, reproducible binding curves.

Buffer Optimization for Small Molecule SPR

For sensor chip selection, refer to our sensor chip selection guide.

Sample Preparation Best Practices

Preparation sequence

• Stock solution: Prepare in 100% DMSO at 10–100 mM. Verify dissolution visually and by UV absorbance.
• Intermediate dilution: Dilute stocks into DMSO to create a uniform intermediate concentration series.
• Final dilution: Dilute into running buffer. Final DMSO must match the running buffer exactly.
• Centrifugation: 14,000 × g for 10 min to remove micro-precipitates. Transfer supernatant.
• Load into glass vials: DMSO leaches plasticizers from plastic—use glass only.

Concentration series design

• Top concentration: 10× to 100× expected KD (solubility-limited)
• Number of points: 6–8 concentrations (including zero)
• Dilution factor: 2-fold or 3-fold series
• Replicates: Duplicate injections at each concentration
• Order: Randomized to reduce systematic drift artifacts

DMSO matching protocol

• Prepare running buffer with exact target DMSO percentage
• Prepare all solutions from the same DMSO lot
• Serial-dilute from a single DMSO-matched master mix
• Target matching to ≤0.1% DMSO difference (optimally 0.05%)
• Verify: inject buffer-only sample at target DMSO—post-correction response should be near zero

Immobilization Strategy for Small Molecule Detection

Capture methods: His-tag or GST-tag capture preserves protein orientation and allows surface regeneration. Biotin-streptavidin capture provides stable, oriented immobilization for long kinetic experiments. Direct amine coupling is simpler but may reduce activity if reactive lysines are near the binding site.

Comparative SPR detection signal: small molecule analytes (MW < 1,000 Da) require 5–10× higher ligand immobilization density than protein analytes to achieve detectable Rmax values.

Mandatory Controls and Quality Metrics

Quality metrics

• Baseline stability: drift < 1 RU/min
• Calibration R² > 0.99
• Chi² < 10% of Rmax (or < 1 RU)
• Duplicate injections overlap within ±10%
• Sample bulk response falls within calibrated DMSO range

Common Pitfalls and Troubleshooting

Complementary Methods for Small Molecule Binding Validation

SPR data for small molecules should ideally be corroborated by an orthogonal method. Isothermal Titration Calorimetry (ITC) provides label-free, solution-phase KD without immobilization artifacts. Microscale Thermophoresis (MST) measures binding in free solution and tolerates DMSO up to 5%. These techniques can serve as independent validation of SPR-derived kinetic parameters, particularly when confirming hits from a fragment screen before advancing to more resource-intensive characterization.

For end-to-end support with small molecule binding studies — including immobilization optimization, solvent correction, and kinetic analysis — see our SPR service for drug discovery and biomolecular interaction studies.

FAQ

What is the maximum DMSO concentration I can use in an SPR experiment?

Most immobilized proteins tolerate up to 5% DMSO (v/v) without significant activity loss. Concentrations above 5% increase the risk of protein denaturation, bulk refractive index artifacts, and decreased sensor chip lifetime. Always test your specific protein target at the planned DMSO concentration before running full kinetics.

How do I know if my compound is aggregating during the SPR run?

Key indicators include spike-like features in the sensorgram, large bulk responses that don't subtract cleanly, injection-order-dependent responses, and signal on the reference surface. Pre-run DLS or nephelometry screening is the best prevention. Centrifuge samples before loading.

Do I need a reference surface for small molecule SPR?

Yes. A reference surface—an activated and blocked flow cell without protein—is essential for subtracting non-specific binding, bulk refractive index changes, and DMSO-induced artifacts. Both single-reference and double-referencing approaches are standard.

What is the smallest molecular weight I can detect by SPR?

With modern Biacore instruments (e.g., Biacore 8K, T200, S200), compounds as small as 100–150 Da can be reliably detected when the protein is immobilized at 5,000–15,000 RU and the binding affinity is in the nM–µM range.

Can I use solvents other than DMSO for small molecule SPR?

Yes. Ethanol (≤2%), acetonitrile (≤1%), and methanol (≤2%) are sometimes used. Each co-solvent requires a dedicated solvent correction curve using the same solvent system. DMSO remains the preferred choice due to its broad solubilization capacity and well-characterized behavior.

How often should I re-run the DMSO calibration?

Re-inject the calibration series at the start, periodically during long runs (every 50–100 cycles), and at the end. DMSO evaporates over time, causing the calibration to drift. Running calibration at three time points allows interpolation correction for samples between runs.

What is the excluded volume effect and why does it matter?

The carboxymethyl-dextran matrix swells in DMSO-containing buffer, and the immobilized protein displaces buffer within the evanescent volume. Because the active and reference surfaces contain different amounts of mobile DMSO, a simple reference subtraction is insufficient. Solvent correction using a calibration curve is required.

Can BLI be used instead of SPR for DMSO-containing samples?

Bio-Layer Interferometry (BLI) is largely insensitive to bulk refractive index because its signal comes from a path-length change at the tip. However, DMSO can still cause non-specific binding and tip-matrix effects. Use a matched reference sensor dipped in the same DMSO-containing buffer.

Related Services